Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study

OBJECTIVES: Iguratimod, a novel immunomodulatory agent for rheumatoid arthritis, has been shown to be effective against murine lupus. The aim of this study was to make a preliminary evaluation of the efficacy and safety of iguratimod as salvage therapy in patients with refractory lupus nephritis (LN...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Kang, Yuening, Yan, Qingran, Fu, Qiong, Wang, Ran, Dai, Min, Du, Fang, Dai, Qing, Ye, Ping, Wu, Chunmei, Lu, Liangjing, Bao, Chunde
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7106733/
https://ncbi.nlm.nih.gov/pubmed/32228698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02154-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars